Dosing Errors Can Derail Your Progress GLP-1 medications must be started at a low dose and increased gradually over time
Stick to your healthy eating and exercise routines even when its challenging
For the broader research view, see the Glow Stack research guide on each compound's role, study context, and safety notes
While there have been no comparable studies conducted in the ICU, recent retrospective reviews have shown that concerns regarding GLP-1RA effects on gastrointestinal complications may have been overstated both in the perioperative setting ( , ) and during endoscopic procedures ( , )
CAR-T cell therapies have shown remarkable success in hematological malignancies and are being actively investigated for solid tumors, including GI cancers
Studies specifically in muscle cells have shown that IGF-1 LR3 activates mTOR signaling, increases phosphorylation of p70S6K and 4E-BP1, enhances myotube formation, increases myotube diameter (hypertrophy), and promotes satellite cell activation more effectively than native IGF-1